Shares of Novocure are traded on the NASDAQ Global Select Stock Market under the ticker symbol NVCR.
When did Novocure go public?
Novocure started trading publicly on October 2, 2015.
Where is Novocure's corporate headquarters?
Novocure is headquartered in the Bailiwick of Jersey.
When does Novocure's fiscal year end?
Who is Novocure's transfer agent?
Our transfer agent is Computershare Shareowner Services LLC. There are a number of ways to contact Computershare to access information in connection with your account. Note: you will need to supply your tax identification number and contact information, including address.
Investor Centre™ website:
Manage your account online via Computershare’s secure Web-based shareholder tool at http://www.computershare.com/investor. Through free, around-the-clock access to the website, you can:
View your account details and update account information
Access tax forms
Enroll in eDelivery to receive shareholder materials electronically
By regular mail:
P.O. Box 43070
Providence, RI 02940-3070
By overnight delivery:
250 Royall Street
Canton, MA 02021
How do I change the address on my stockholder account?
If you own shares through a brokerage firm, you need to contact that firm directly to change your account address.
If you own shares in the form of a stock certificate, you may update your address by contacting our transfer agent, Computershare Shareowner Services LLC, at 877-419-8459 or via their website at https://www-us.computershare.com/investor.
How can I buy Novocure stock?
Shares can be purchased through a stockbroker of your choice. Novocure does not have a direct stock purchase program.
What is Novocure's CUSIP number?
Our ordinary shares CUSIP number is G6674U 108.
Who are the independent auditors?
Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
sign up for email alerts
To receive notifications via email, enter your email address and select at least one subscription below. After submitting your information, you will receive an email. You must click the link in the email to activate your subscription. You can sign up for additional subscriptions at any time.
clinical trialsOur mechanism of action is broadly applicable across a variety of solid tumors.
publicationsWe have more than 15 years of research and multiple peer-reviewed publications with pre-clinical data in 15 cancer types and clinical data in eight cancer types.
novocuretrial.comThe science of Tumor Treating Fields extends beyond glioblastoma. We are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.